Home/Filings/4/0001437749-21-005145
4//SEC Filing

Latour Wouter 4

Accession 0001437749-21-005145

CIK 0000072444other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:03 PM ET

Size

17.6 KB

Accession

0001437749-21-005145

Insider Transaction Report

Form 4
Period: 2021-03-04
Latour Wouter
DirectorPresident and Chief Executive
Transactions
  • Exercise/Conversion

    Common Stock

    2021-03-04$0.77/sh+150,000$115,500150,000 total
  • Sale

    Common Stock

    2021-03-04$6.04/sh150,000$906,4500 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-03-04150,000213,261 total
    Exercise: $0.77Exp: 2029-05-11Common stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter.

Issuer

Vaxart, Inc.

CIK 0000072444

Entity typeother

Related Parties

1
  • filerCIK 0001652203

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:03 PM ET
Size
17.6 KB